<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39306193</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Rational design of a DNA-launched live attenuated vaccine against human enterovirus 71.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1995-820X(24)00147-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virs.2024.09.008</ELocationID><Abstract><AbstractText>Human Enterovirus 71 (EV71) has emerged as one of the predominant causative agents of hand, foot and mouth disease (HFMD) with global impact. Despite the inactivated vaccine being licensed, other vaccine candidates based on advanced technology platforms are under development. In this report, we rationally designed and constructed two DNA-launched live attenuated vaccine candidates (pDL-EV71) under the control of specific promoters. In vitro and in vivo transfection with pDL-EV71 driven by the CMV promoter successfully yielded fully infectious EV71. More importantly, the administration of pDL-EV71 did not cause clinical symptoms following intracranial or intramuscular inoculation in neonatal and IFNα/βR<sup>-/-</sup> mice, demonstrating its safety profile. Moreover, a single-dose or two-dose immunization with pDL-EV71 elicited robust neutralizing antibodies against EV71 as well as an antigen-specific cellular response in mice. A single-dose immunization with 10 ​μg of pDL-EV71 conferred complete protection against lethal EV71 infection in neonates born to immunized maternal mice. Overall, our present results demonstrate that pDL-EV71 is a safe and effective vaccine candidate against EV71 for further development.</AbstractText><CopyrightInformation>Copyright © 2024 The Authors. Publishing services by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Rong-Rong</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Meng-Jiao</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yan-Peng</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Tian-Shu</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zheng-Jian</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Mei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ming</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yi-Jiao</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Meng-Xu</ForeName><Initials>MX</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Yong-Qiang</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiao-Feng</ForeName><Initials>XF</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College (SHMC), Fudan University, Shanghai, 200032, China; Advaccine Biopharmaceutics (Suzhou) Co. LTD, Suzhou, 215000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China. Electronic address: yy.0526@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Cheng-Feng</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, AMMS, Beijing, 100071, China. Electronic address: qincf@bmi.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA vaccine</Keyword><Keyword MajorTopicYN="N">DNA-launched vaccine</Keyword><Keyword MajorTopicYN="N">Hand, foot and mouth disease (HFMD)</Keyword><Keyword MajorTopicYN="N">Human enterovirus 71 (EV71)</Keyword><Keyword MajorTopicYN="N">Live attenuated vaccine</Keyword></KeywordList><CoiStatement>Conflict of interest Prof. Cheng-Feng Qin is an editorial board member for Virologica Sinica and was not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>22</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>22</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>21</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39306193</ArticleId><ArticleId IdType="doi">10.1016/j.virs.2024.09.008</ArticleId><ArticleId IdType="pii">S1995-820X(24)00147-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle>